All Publications

Journals

• Keun HC; Sidhu J; Pchejetski D; Lewis JS; Marconell H; Patterson M; Bloom SR; Amber V; et al. (1 Nov 2009). Serum Molecular Signatures of Weight Change during Early Breast Cancer Chemotherapy. CLIN CANCER RES. 15:6716-6723. DOI.
• Sauer L; Nunes J; Salunkhe V; Skalska L; Kohama T; Cuvillier O; Waxman J; Pchejetski D. (1 Dec 2009). Sphingosine kinase 1 inhibition sensitizes hormone-resistant prostate cancer to docetaxel. Int J Cancer. 125:2728-2736. DOI.
• Guillermet-Guibert J; Davenne L; Pchejetski D; Saint-Laurent N; Brizuela L; Guilbeau-Frugier C; Delisle MB; Cuvillier O; et al. (Apr 2009). Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug. MOL CANCER THER. 8:809-820. DOI.
• Malavaud B; Pchejetski D; Mazerolles C; Calvet C; Doumerc N; Pitson S; Rischmann P; Cuvillier O. (Oct 2008). Correlation between sphingosine kinase-1 oncogene activity and the tumoral grade of prostatic tissues removed from radical prostatectomy. B CANCER. 95:S20-S21.
• Pchejetski D; Doumerc N; Golzio M; Naymark M; Teissie J; Kohama T; Waxman J; Malavaud B; et al. (Jul 2008). Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models. MOL CANCER THER. 7:1836-1845. DOI.
• Gomez-Brouchet A; Pchejetski D; Brizuela L; Garcia V; Altié MF; Maddelein ML; Delisle MB; Cuvillier O. (Aug 2007). Critical role for sphingosine kinase-1 in regulating survival of neuroblastoma cells exposed to amyloid-beta peptide. Mol Pharmacol. 72:341-349. DOI.
• Taurin S; Dulin NO; Pchejetski D; Grygorczyk R; Tremblay J; Hamet P; Orlov SN. (15 Sep 2002). c-Fos expression in ouabain-treated vascular smooth muscle cells from rat aorta: evidence for an intracellular-sodium-mediated, calcium-independent mechanism. J Physiol. 543:835-847.
• Pchejetski D; Taurin S; Der Sarkissian S; Lopina OD; Pshezhetsky AV; Tremblay J; deBlois D; Hamet P; et al. (14 Feb 2003). Inhibition of Na+,K+-ATPase by ouabain triggers epithelial cell death independently of inversion of the [Na+]i/[K+]i ratio. Biochem Biophys Res Commun. 301:735-744.
• Orlov SN; Pchejetski DV; Sarkissian SD; Adarichev V; Taurin S; Pshezhetsky AV; Tremblay J; Maximov GV; et al. (Mar 2003). [3H]-thymidine labelling of DNA triggers apoptosis potentiated by E1A-adenoviral protein. Apoptosis. 8:199-208.
• Brindikova TA; Bourcier N; Torres B; Pchejetski D; Gekle M; Maximov GV; Montminy V; Insel PA; et al. (Dec 2003). Purinergic-induced signaling in C11-MDCK cells inhibits the secretory Na-K-Cl cotransporter. Am J Physiol Cell Physiol. 285:C1445-C1453. DOI.
• Orlov SN; Pchejetski D; Taurin S; Thorin-Trescases N; Maximov GV; Pshezhetsky AV; Rubin AB; Hamet P. (Jan 2004). Apoptosis in serum-deprived vascular smooth muscle cells: evidence for cell volume-independent mechanism. Apoptosis. 9:55-66. DOI.
• Orlov SN; Thorin-Trescases N; Pchejetski D; Taurin S; Farhat N; Tremblay J; Thorin E; Hamet P. (Jun 2004). Na+/K+ pump and endothelial cell survival: [Na+]i/[K+]i-independent necrosis triggered by ouabain, and protection against apoptosis mediated by elevation of [Na+]i. Pflugers Arch. 448:335-345. DOI.
• Le Scolan E; Pchejetski D; Banno Y; Denis N; Mayeux P; Vainchenker W; Levade T; Moreau-Gachelin F. (1 Sep 2005). Overexpression of sphingosine kinase 1 is an oncogenic event in erythroleukemic progression. Blood. 106:1808-1816. DOI.
• Akimova OA; Pchejetski D; Hamet P; Orlov SN. (Jan 2006). Modest intracellular acidification suppresses death signaling in ouabain-treated cells. Pflugers Arch. 451:569-578. DOI.
• Bonhoure E; Pchejetski D; Aouali N; Morjani H; Levade T; Kohama T; Cuvillier O. (Jan 2006). Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting sphingosine kinase-1. Leukemia. 20:95-102. DOI.
• Pchejetski D; Golzio M; Bonhoure E; Calvet C; Doumerc N; Garcia V; Mazerolles C; Rischmann P; et al. (15 Dec 2005). Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models. Cancer Res. 65:11667-11675. DOI.
• Pchejetski D; Kunduzova O; Dayon A; Calise D; Seguelas MH; Leducq N; Seif I; Parini A; et al. (5 Jan 2007). Oxidative stress-dependent sphingosine kinase-1 inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis. Circ Res. 100:41-49. DOI.

Chapters in books

• Cuvillier O; Bonhoure E; Dayon A; Martin C; Malavaud B; Pchejetski D; Rischmann P. The ceramide/sphingosine 1-phosphate biostat in cancer and the role of sphingosine kinase-1 as a therapeutic target. In Sphingolipids and cell function. Albi E (ed). Transworld Research Network, Trivandrum (2006).